Patents by Inventor Roop Singh Bora

Roop Singh Bora has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10292972
    Abstract: A pharmaceutical composition containing an anticancer compound, named isopicrinine, isolated from the plant Rhazya Stricta. The pharmaceutical composition may contain a salt, an analog, a derivative, and/or the prodrug of isopicrinine. A method of treating cancer with the pharmaceutical composition is disclosed. A method of extracting isopicrinine is also disclosed.
    Type: Grant
    Filed: October 26, 2017
    Date of Patent: May 21, 2019
    Assignee: King Abdulaziz University
    Inventors: Jamal Sabir M. Sabir, Abdullah Y. Obaid, Nahid H. Hajrah, Waseem Mohammed, Zainab H. Abdul-Hameed, Walied M. Alarif, Roop Singh Bora, Seif-Eldin N. Ayyad, Nouf Saeed A. Al-Abbas, Abdulkader M. Shaikh Omer, Mohammed Zainy Mutawakil, Neil Hall, Kulvinder Singh Saini
  • Publication number: 20190125732
    Abstract: A pharmaceutical composition containing an anticancer compound, named isopicrinine, isolated from the plant Rhazya Stricta. The pharmaceutical composition may contain a salt, an analog, a derivative, and/or the prodrug of isopicrinine. A method of treating cancer with the pharmaceutical composition is disclosed. A method of extracting isopicrinine is also disclosed.
    Type: Application
    Filed: October 26, 2017
    Publication date: May 2, 2019
    Applicant: King Abdulaziz University
    Inventors: Jamal Sabir M. SABIR, Abdullah Y. OBAID, Nahid H. HAJRAH, Waseem MOHAMMED, Zainab H. ABDUL-HAMEED, Walied M. ALARIF, Roop Singh BORA, Seif-Eldin N. AYYAD, Nouf Saeed A. AL-ABBAS, Abdulkader M. Shaikh OMER, Mohammed Zainy MUTAWAKIL, Neil HALL, Kulvinder Singh SAINI
  • Patent number: 5683866
    Abstract: This invention relates to a reconstituted sendai-viral envelope containing the F-protein (F-virosomes) and to a process for producing a targeted gene or drug delivery carrier produced by the steps of chemical reduction of Sendai virus for reduction of HN protein and subjecting the reduced virus to the step of dialysis for removal of the reducing agent. The reduced virus is then solubilized with a detergent to obtain a solution. The said solution is centrifuged to separate the insolubles consisting of reduced HN protein and core of the virus, adding the required specific gene or drug to the centrifugal solution. Finally, the detergent is removed using an affinity complex agent which binds the detergent leading to the formation of the delivery carrier.
    Type: Grant
    Filed: May 9, 1996
    Date of Patent: November 4, 1997
    Inventors: Debi P. Sarkar, Komal Ramani, Roop Singh Bora, Mukejn Kumar, Sandeep K. Tyagi